In-vitro is a complicated, expensive procedure that isn’t usually covered by insurance. So it would make sense that before the procedure is started, all interested parties have a good idea about the chance of success. The problem is that age is the main metric used to determine the chances of in-vitro success, and it’s not all that great; it has a high rate of false negatives. That may be changing–startup California company Univfy is presenting a new algorithm to the AMerican Society of Reproductive Medicine tomorrow that is 36% more accurate than age alone at determining fertility. (more…)
By Ubergizmo. Related articles: LG gives you the illusion of free falling in an elevator with new displays, Iron Man 3 official trailer sees debut of Mandarin,
